Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Regeneron Pharmaceuticals, Inc.
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.
Market Capitalisation
$75.84B
Price-earnings ratio
-
Dividend yield
0.52%
Volume
879.37K
High today
$730.59
Low today
$709.51
Open price
$721.29
52-week high
$821.11
52-week low
$476.49
Ready to start your investing journey with Stake?
Open an accountHow do I buy REGN shares in Australia?
Buying REGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Regeneron Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in REGN
What is the ticker symbol of Regeneron Pharmaceuticals, Inc.?
The ticker symbol for Regeneron Pharmaceuticals, Inc. is REGN.
How much is one share of REGN?
One share of REGN is valued at $720.27 as of 14 May 2026.
What is the market capitalisation of Regeneron Pharmaceuticals, Inc. REGN?
As of 14 May 2026 Regeneron Pharmaceuticals, Inc. has a market cap of $75.84B.
Does REGN pay dividends?
Yes, REGN does pay dividends.
What is the dividend yield for REGN?
The dividend yield for REGN is 0.52% as of 14 May 2026.
What is the P/E ratio of REGN?
The Price to Earnings ratio of REGN is 17.46.
What is the Earnings Per Share of REGN?
The Earnings Per Share of REGN is $41.44.
What is the 52-week high for Regeneron Pharmaceuticals, Inc. stock?
The Regeneron Pharmaceuticals, Inc. 52-week high stock price is $821.11.
What is the 52-week low for Regeneron Pharmaceuticals, Inc. stock?
The Regeneron Pharmaceuticals, Inc. 52-week low stock price is $476.49.
Can I buy REGN shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy REGN shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in REGN on Stake
- Buy REGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of REGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
REGN related stocks